M
Mohammad Aghazadeh
Researcher at Tabriz University of Medical Sciences
Publications - 116
Citations - 2450
Mohammad Aghazadeh is an academic researcher from Tabriz University of Medical Sciences. The author has contributed to research in topics: Enterococcus faecalis & Pseudomonas aeruginosa. The author has an hindex of 26, co-authored 96 publications receiving 1854 citations. Previous affiliations of Mohammad Aghazadeh include Tarbiat Modares University & Mazandaran University of Medical Sciences.
Papers
More filters
Journal ArticleDOI
Role of oral microbiome on oral cancers, a review.
Pourya Gholizadeh,Hosein Eslami,Mehdi Yousefi,Mohammad Asgharzadeh,Mohammad Aghazadeh,Hossein Samadi Kafil +5 more
TL;DR: The association between the development of oral cancer in potentially malignant oral lesions with chronic periodontitis, chronic Porphyromonas gingivalis, Fusobacterium nucleatum, candida, other microbes and described mechanisms which may be involved in these carcinoma are discussed.
Journal ArticleDOI
Synthesis and characterization of antibacterial carboxymethyl cellulose/ZnO nanocomposite hydrogels
TL;DR: The developed carboxymethyl cellulose/ZnO nanocomposite hydrogels can be used effectively for biomedical application and demonstrated antibacterial effects against Escherichia coli and Staphylococcus aureus bacteria.
Journal ArticleDOI
Synthesis and characterization of antibacterial carboxymethylcellulose/CuO bio-nanocomposite hydrogels.
TL;DR: The developed carboxymethyl cellulose/CuO nanocomposite hydrogels can be used effectively for biomedical application and demonstrated excellent antibacterial effects.
Journal ArticleDOI
Antibacterial carboxymethyl cellulose/Ag nanocomposite hydrogels cross-linked with layered double hydroxides.
TL;DR: The antibacterial activity of CMC-LDHs increased considerably after formation of AgNPs and was stable for more than one month and the prepared hydrogels showed a pH sensitive swelling behavior.
Journal ArticleDOI
How CRISPR-Cas System Could Be Used to Combat Antimicrobial Resistance
Pourya Gholizadeh,Sukran Kose,Sounkalo Dao,Khudaverdi Ganbarov,Asghar Tanomand,Tuba Dal,Mohammad Aghazadeh,Reza Ghotaslou,Mohammad Ahangarzadeh Rezaee,Bahman Yousefi,Hossein Samadi Kafil +10 more
TL;DR: It is envisioned that CRISPR-Cas approaches may open novel ways for the development of smart antibiotics, which could eliminate multidrug-resistant (MDR) pathogens and differentiate between beneficial and pathogenic microorganisms.